Imtiyaz Basade appointed Senior VP of NATCO Pharma
He has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends.
He has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends.
Company receives acceptability, in principle, for ZyVac TCV making it eligible for purchase by United Nations procurement agencies
Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
USFDA completes PAI of Lupin’s biotech facility in Pune
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
Stable profits, low leverage to keep credit profiles comfortable
Subscribe To Our Newsletter & Stay Updated